Clinical Trials · NCT07035093
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Eli Lilly and Company
- Enrollment
- 586
- Start date
- May 2025
- Locations
- 40 sites, 4 countries
- Primary endpoint
- Change from Baseline in Pain Intensity Per Numeric Rating Scale